Chicago, IL, November 06, 2014 -- /EPR NETWORK/ -- Packaging engineers in the pharmaceutical space now have the opportunity to discuss the latest trends in primary, secondary, and tertiary packaging, sustainability, globalization and much more at the Pharmaceutical and Biotech Package Design and Engineering Conference, January 29-30, 2015 in Philadelphia, Pennsylvania. The conference will host executive leaders from small, medium, and large pharmaceutical organizations and open the floor to discussion of the most top-of-mind issues and concerns.
A wide variety of session topics focusing on the most relevant items including the evolution of packaging requirements, prevention of counterfeit products, augmenting patient compliance, and streamlining the package development processes will be led by some of the biggest names in the industry. More than a dozen distinguished presenters will be on hand to lead sessions, panels and case studies, including Walter Berghahn of HCPC, Reid Graves of Pfizer, Philip Dahlin of Johnson & Johnson, and Kelley Frank of Johnson & Johnson.
During the conference, interactive case studies will be presented by companies who have seen success in various areas of pharmaceutical packaging. Arun Madanagopal of ThermoFisher Scientific will lead a case study on the ever-increasing need for cold-chain packaging and best practices for minimizing costs, implementing new materials and designs, and ensuring product safety. Jan Gates of the Institute of Packaging Professionals will offer her insight on tertiary packaging testing and how it pertains to ensuring product safety during transport.
For more information on the Pharmaceutical and Biotech Package Design and Engineering Conference, please visit www.q1productions.com/pharmapackaging or contact email@example.com. You can also follow the conference on Twitter @Q1Productions, #RxPak15.
About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.
Contact-Details: Erica Abdnour